Main

Fields of interest:

• Alzheimer's disease
• Behavioral neurology of basal ganglia disorders
• Depression in elderly
• Psychosomatic medicine
  
  

Recent publications:

T. Sobow, M. Flirski, I. Kloszewska and P.P. Liberski:
Plasma A? levels as predictors of response to rivastigmine treatment in Alzheimer's disease,
Acta Neurobiol. Exp., 2007 (in press).

T. Sobow, M. Flirski, P.P. Liberski and I. Kloszewska:
Plasma A? peptides and apolipoprotein E in Alzheimer's disease and mild cognitive impairment,
Arch. Psychiatr. Psychother., 2007 (in press).

T. Sobow and I. Kloszewska:
Cholinesterase inhibitors in mild cognitive impairment: a meta-analysis of randomized controlled trials,
Neurol. Neurochir. Pol., Vol. 41(1), (2007), pp. 13-21.

T. Sobow:
Cholinesterase inhibitors for Parkinson's disease visual hallucinations unresponsive to atypical antipsychotics,
Arch. Med. Sci., Vol. 3(1), 2007, pp. 69-72.

T. Sobow and I. Kloszewska:
Cholinesterase inhibitors in the "real-world" setting: rivastigmine versus donepezil tolerability and effectiveness study,
Arch. Med. Sci., Vol. 2(3), 2006, pp. 194-198.

M. Flirski and T. Sobow:
Biochemical markers and risk factors of Alzheimer`s disease,
Curr. Alzheimer Res., Vol. 2(1), 2005, pp. 47-64.

T. Sobow, M. Flirski, I. Kloszewska and P.P. Liberski: Plasma levels of Aß peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer`s disease,
Acta Neurobiol. Exp., Vol. 65(3), 2005, pp.117-124.

T. Sobow and I. Kloszewska:
Short-term treatment with rivastigmine and plasma levels of Aß peptides in Alzheimer`s disease,
Folia Neuropathol., Vol. 43(4), 2005, pp. 340-344.